WAM
NBIX icon

World Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

World Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$305K Sell
3,178
-133
-4% -$12.6K 0.03% 612
2021
Q2 		$322K Sell
3,311
-127
-4% -$12.2K 0.03% 634
2021
Q1 		$325K Buy
+3,438
New +$361K 0.03% 649
2020
Q3 		– Sell
-1,656
Closed -$202K – 801
2020
Q2 		$202K Buy
+1,656
New +$183K 0.02% 706
2020
Q1 		– Sell
-2,610
Closed -$281K – 1015
2019
Q4 		$281K Sell
2,610
-396
-13% -$41.5K 0.01% 830
2019
Q3 		$271K Buy
3,006
+39
+1% +$3.64K 0.01% 880
2019
Q2 		$251K Sell
2,967
-22
-0.7% -$1.81K 0.01% 942
2019
Q1 		$263K Sell
2,989
-49
-2% -$4.1K 0.01% 906
2018
Q4 		$217K Sell
3,038
-156
-5% -$14.9K 0.01% 908
2018
Q3 		$393K Buy
3,194
+40
+1% +$4.54K 0.02% 809
2018
Q2 		$310K Sell
3,154
-80
-2% -$7.16K 0.02% 931
2018
Q1 		$268K Sell
3,234
-728
-18% -$61.5K 0.01% 1055
2017
Q4 		$307K Sell
3,962
-60
-1% -$4.09K 0.01% 1124
2017
Q3 		$246K Buy
+4,022
New +$212K 0.01% 1253

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

World Asset Management's NBIX Position: Q3 2021 in Review

World Asset Management reduced its Neurocrine Biosciences (NBIX) stake by 4% in Q3 2021, selling an estimated $12.6K and leaving 3,178 shares worth $305K. The position accounts for 0.03% of the portfolio, ranked #612.

World Asset Management first reported a position in NBIX in Q3 2017 and has held it in 14 quarters since. The position peaked at $393K in Q3 2018. 395 funds tracked by Wall St. Rank hold NBIX as of Q3 2021.

  • World Asset Management held 3,178 shares of Neurocrine Biosciences worth $305K as of Q3 2021.
  • World Asset Management sold 133 Neurocrine Biosciences shares in Q3 2021, an estimated $12.6K.
  • Neurocrine Biosciences made up 0.03% of World Asset Management's portfolio in Q3 2021, its #612 holding.
  • World Asset Management first reported a position in Neurocrine Biosciences in Q3 2017 and has held it in 14 quarters since.
  • World Asset Management's Neurocrine Biosciences position peaked at $393K in Q3 2018.
  • 395 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.